Rabello Imbrizi Marcello, Lopes Secundo Tirzah, Magro Daniela, Lahan-Martins Daniel, Trevisan Miriam, de Pinho Junior Antônio, Cabral Virgínia, Coy Claudio
IBD Outpatients Unit, Gastrocenter, University of Campinas, Campinas, Brazil.
UNICAMP, Campinas, Brazil.
Am J Gastroenterol. 2021 Dec 1;116(Suppl 1):S17. doi: 10.14309/01.ajg.0000798856.73091.69.
Background: CD is an inflammatory disease that predominantly affects the gastrointestinal tract and has a progressive course. Immunodeficiencies can occur by altering different components of innate or adaptive immune responses. Such changes put the patient at greater risk for infectious diseases or non-infectious complications. Among the non-infectious complications are cancer, autoimmune diseases and gastrointestinal diseases, which should be suspected in patients with recurrent infections, with clinical, radiological or histological features of the disease are atypical or in the occurrence of an unsatisfactory response to conventional therapy.
To describe a case report of a CD patient complicated with enteric alterations related to immunodeficiency.
A 31-year-old male patient started presenting abdominal pain, diarrhea, and weight loss in October 2020. He underwent a colonoscopy that showed diffuse involvement of the colon suggestive of CD. He didn`t respond to therapy with prednisone and azathioprine and lost 40kg until January 2021, when he was referred to an IBD center. He had signs of malnutrition (eg, BMI = 15.4, Albumin = 1.8g/dL). The MRI showed diffuse thickening of the walls of the entire length of the ileum, colon and rectum, associated with submucosal edema and more intense enhancement in the inner layer. Findings compatible with nonspecific diffuse ileocolitis. After negative infectious screening, hydrocortisone, azathioprine and infliximab were prescribed, but the patient remained clinical worsening. During the 6 weeks of therapy use, the patient presented oral candidiasis, septic pyoarthritis, DNA testing for Clostridium difficile and PCR for Cytomegalovius were positive. Despite the treatment of infectious diseases, the patient continued to worsen and was considered a primary non-response to anti-TNF, opting for the initiation of Ustekinumab. There was improvement in endoscopic and fecal calprotectin, but continued progression of ileal disease and diarrhea, with no response to enteral or parenteral nutritional therapies. An investigation for immunodeficiencies was carried out and IgM/IgG deficiency was noted, and parenteral immunoglobulin was started. He presented an intestinal subocclusion, requiring a loop ileostomy. In this surgery, it was decided to send a sample of ileal tissue for diagnostic differentiation, where ileitis was observed with intense plasma cell reaction and lymphoid nodular hyperplasia, uncharacteristic of DC, which may correspond to enteropathy secondary to immunodeficiency. Despite the treatment, the patient presented fungal endocarditis, esophageal moniliasis and septic condition of undetermined origin. He remained in hospital for 120 days until complete improvement of the infectious complications. With the slow improvement in nutritional parameters, there was a reduction in the incidence of infections as well as an increase in immunoglobulins. After five months of combined nutrition and anti-interleukin therapy, the patient presented clinical improvement, weight gain and complete normalization of IgG and IgM. Ileal disease is in regression and in the colon, in endoscopic remission.
We present a case report of the initial presentation of DC complicated with severe malnutrition where there was depletion of part of immunoglobulins, resulting in infectious and non-infectious complications, where ileal involvement intensified the manifestation of colonic DC.
背景:克罗恩病(CD)是一种主要累及胃肠道且呈进行性发展的炎症性疾病。免疫缺陷可通过改变固有免疫或适应性免疫反应的不同成分而发生。这些变化使患者更容易发生感染性疾病或非感染性并发症。非感染性并发症包括癌症、自身免疫性疾病和胃肠道疾病,对于反复感染、具有非典型临床、放射学或组织学特征的疾病或对传统治疗反应不佳的患者,应怀疑存在这些并发症。
描述1例合并免疫缺陷相关肠道改变的CD患者的病例报告。
一名31岁男性患者于2020年10月开始出现腹痛、腹泻和体重减轻。他接受了结肠镜检查,结果显示结肠弥漫性受累,提示为CD。他对泼尼松和硫唑嘌呤治疗无反应,到2021年1月体重减轻了40kg,随后被转诊至炎症性肠病中心。他有营养不良的体征(如体重指数=15.4,白蛋白=1.8g/dL)。磁共振成像(MRI)显示回肠、结肠和直肠全长肠壁弥漫性增厚,伴有黏膜下水肿和内层强化更明显。结果符合非特异性弥漫性回结肠炎。在感染筛查结果为阴性后,给予氢化可的松、硫唑嘌呤和英夫利昔单抗治疗,但患者病情仍持续恶化。在治疗的6周内,患者出现口腔念珠菌病、脓毒性化脓性关节炎,艰难梭菌DNA检测和巨细胞病毒聚合酶链反应(PCR)均为阳性。尽管对感染性疾病进行了治疗,但患者病情仍继续恶化,被认为是对肿瘤坏死因子(TNF)治疗原发性无反应,于是开始使用乌司奴单抗。内镜检查和粪便钙卫蛋白有所改善,但回肠疾病和腹泻仍持续进展,对肠内或肠外营养治疗无反应。对免疫缺陷进行了检查,发现存在IgM/IgG缺陷,于是开始给予肠外免疫球蛋白治疗。他出现了肠道不全梗阻,需要进行回肠袢造口术。在这次手术中,决定取一段回肠组织样本进行诊断鉴别,结果观察到回肠炎伴强烈的浆细胞反应和淋巴小结增生,这并非克罗恩病的特征,可能对应于免疫缺陷继发的肠病。尽管进行了治疗,患者仍出现真菌性心内膜炎、食管念珠菌病和不明原因的脓毒症。他住院120天,直到感染并发症完全改善。随着营养参数的缓慢改善,感染发生率降低,免疫球蛋白增加。经过5个月的营养和抗白细胞介素联合治疗,患者临床症状改善,体重增加,IgG和IgM完全恢复正常。回肠疾病正在消退,结肠处于内镜缓解期。
我们报告了1例初发的克罗恩病合并严重营养不良的病例,其中部分免疫球蛋白耗竭,导致感染性和非感染性并发症,回肠受累加重了结肠克罗恩病的表现。